These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29268772)

  • 1. A functional role of LEFTY during progesterone therapy for endometrial carcinoma.
    Fei W; Kijima D; Hashimoto M; Hashimura M; Oguri Y; Kajita S; Matsumoto T; Yokoi A; Saegusa M
    Cell Commun Signal; 2017 Dec; 15(1):56. PubMed ID: 29268772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirements of LEFTY and Nodal overexpression for tumor cell survival under hypoxia in glioblastoma.
    Matsumoto T; Chino H; Akiya M; Hashimura M; Yokoi A; Tochimoto M; Nakagawa M; Jiang Z; Saegusa M
    Mol Carcinog; 2020 Dec; 59(12):1409-1419. PubMed ID: 33111989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalk between NF-kappaB/p65 and beta-catenin/TCF4/p300 signalling pathways through alterations in GSK-3beta expression during trans-differentiation of endometrial carcinoma cells.
    Saegusa M; Hashimura M; Kuwata T; Hamano M; Okayasu I
    J Pathol; 2007 Sep; 213(1):35-45. PubMed ID: 17607667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-β-mediated LEFTY/Akt/GSK-3β/Snail axis modulates epithelial-mesenchymal transition and cancer stem cell properties in ovarian clear cell carcinomas.
    Matsumoto T; Yokoi A; Hashimura M; Oguri Y; Akiya M; Saegusa M
    Mol Carcinog; 2018 Aug; 57(8):957-967. PubMed ID: 29603383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation and nuclear localization of beta-catenin in endometrial carcinoma in response to progesterone therapy.
    Saegusa M; Hamano M; Kuwata T; Yoshida T; Hashimura M; Akino F; Watanabe J; Kuramoto H; Okayasu I
    Cancer Sci; 2003 Jan; 94(1):103-11. PubMed ID: 12708483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of nodal signalling components in cycling human endometrium and in endometrial cancer.
    Papageorgiou I; Nicholls PK; Wang F; Lackmann M; Makanji Y; Salamonsen LA; Robertson DM; Harrison CA
    Reprod Biol Endocrinol; 2009 Oct; 7():122. PubMed ID: 19874624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells.
    Bhat KP; Pezzuto JM
    Cancer Res; 2001 Aug; 61(16):6137-44. PubMed ID: 11507064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kruppel-like factor 9 is a negative regulator of ligand-dependent estrogen receptor alpha signaling in Ishikawa endometrial adenocarcinoma cells.
    Velarde MC; Zeng Z; McQuown JR; Simmen FA; Simmen RC
    Mol Endocrinol; 2007 Dec; 21(12):2988-3001. PubMed ID: 17717078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nodal induces apoptosis and inhibits proliferation in ovarian endometriosis-clear cell carcinoma lesions.
    Miura R; Yokoi A; Matsumoto T; Oguri Y; Hashimura M; Tochimoto M; Kajita S; Saegusa M
    BMC Cancer; 2019 Apr; 19(1):308. PubMed ID: 30943930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of uteroglobin in normal and carcinogenic endometrium and influence of hormone replacement therapy.
    Tanaka R; Saito T; Shijubo N; Takehara M; Yamada G; Kawabata I; Itoh Y; Kudo R
    Int J Cancer; 2004 Mar; 109(1):43-8. PubMed ID: 14735466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of endometrial glycogen synthase kinase-3beta protein throughout the menstrual cycle and its regulation by progesterone.
    Salameh W; Helliwell JP; Han G; McPhaul L; Khorram O
    Mol Hum Reprod; 2006 Sep; 12(9):543-9. PubMed ID: 16882987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
    Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of progesterone in endometrial cancer.
    Kim JJ; Chapman-Davis E
    Semin Reprod Med; 2010 Jan; 28(1):81-90. PubMed ID: 20104432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lefty A protein inhibits TGF-β1-mediated apoptosis in human renal tubular epithelial cells.
    Zheng RP; Bai T; Zhou XG; Xu CG; Wang W; Xu MW; Zhang J
    Mol Med Rep; 2013 Aug; 8(2):621-5. PubMed ID: 23807264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lefty inhibits glioma growth by suppressing Nodal-activated Smad and ERK1/2 pathways.
    Sun G; Shi L; Li M; Jiang N; Fu L; Guo J
    J Neurol Sci; 2014 Dec; 347(1-2):137-42. PubMed ID: 25304053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of erythropoietin expression in human endometrial carcinoma.
    Acs G; Xu X; Chu C; Acs P; Verma A
    Cancer; 2004 Jun; 100(11):2376-86. PubMed ID: 15160341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progesterone-dependent release of transforming growth factor-beta1 from epithelial cells enhances the endometrial decidualization by turning on the Smad signalling in stromal cells.
    Kim MR; Park DW; Lee JH; Choi DS; Hwang KJ; Ryu HS; Min CK
    Mol Hum Reprod; 2005 Nov; 11(11):801-8. PubMed ID: 16403803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal and malignant human endometrium express immunohistochemically estrogen receptor alpha (ER-alpha), estrogen receptor beta (ER-beta) and progesterone receptor (PR).
    Mylonas I; Jeschke U; Shabani N; Kuhn C; Kriegel S; Kupka MS; Friese K
    Anticancer Res; 2005; 25(3A):1679-86. PubMed ID: 16033082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional up-regulation of Sox9 by NF-κB in endometrial carcinoma cells, modulating cell proliferation through alteration in the p14(ARF)/p53/p21(WAF1) pathway.
    Saegusa M; Hashimura M; Suzuki E; Yoshida T; Kuwata T
    Am J Pathol; 2012 Aug; 181(2):684-92. PubMed ID: 22698986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor β and Ras/MEK/ERK signaling regulate the expression level of a novel tumor suppressor Lefty.
    Miyata N; Azuma T; Hozawa S; Higuchi H; Yokoyama A; Kabashima A; Igarashi T; Saeki K; Hibi T
    Pancreas; 2012 Jul; 41(5):745-52. PubMed ID: 22441145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.